These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 6234240)

  • 1. Clinical and immunobiological effects of an orally administered bacterial extract.
    Maestroni GJ; Losa GA
    Int J Immunopharmacol; 1984; 6(2):111-7. PubMed ID: 6234240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical and immunobiological action of an orally administered bacterial extract].
    Losa GA; Maestroni GJ
    Schweiz Med Wochenschr; 1984 Jun; 114(25):930-2. PubMed ID: 6235582
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial lysates in the prevention of respiratory tract infections.
    Jurkiewicz D; Zielnik-Jurkiewicz B
    Otolaryngol Pol; 2018 Oct; 72(5):1-8. PubMed ID: 30460909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunologic indicators in the treatment of recurrent respiratory diseases using peroral bacterial vaccines].
    Kapellerová A; Sulko M; Krovinová A; Jakubovská M; Michalicková J; Mazáriková O
    Cesk Pediatr; 1989 Aug; 44(8):454-8. PubMed ID: 2791096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comments on Immune stimulation/-modulation with preparations consisting of extracts of Sun-flower or bacterial lysate].
    Reinhardt D
    Monatsschr Kinderheilkd; 1993 Jul; 141(7):622. PubMed ID: 8413343
    [No Abstract]   [Full Text] [Related]  

  • 6. Respiratory infections in paediatrics: recent findings and prospects.
    Allerg Immunol (Paris); 2002 Jan; 34(1):22-5. PubMed ID: 11878132
    [No Abstract]   [Full Text] [Related]  

  • 7. Effectiveness of thymostimulin and study of lymphocyte-dependent antibacterial activity in children with recurrent respiratory infections.
    De Mattia D; Decandia P; Ferrante P; Pace D; Martire B; Ciccarelli M; Caradonna L; Ribaud MR; Jirillo E; Schettini F
    Immunopharmacol Immunotoxicol; 1993 Aug; 15(4):447-59. PubMed ID: 8227971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical study concerning the prevention of infections of the upper respiratory tract of preschool children].
    Martin du Pan RE; Martin du Pan RC
    Schweiz Rundsch Med Prax; 1982 Sep; 71(36):1385-9. PubMed ID: 6752937
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunologic heterogeneity of the lymphocyte surface in various diseases.
    Nowak J; Horst A
    Ann Med Sect Pol Acad Sci; 1975; 20(3):173-84. PubMed ID: 1103513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of upper respiratory tract infections with broncho-vaxom++: a therapeutic alternative to chemotherapy?].
    Tarchalska-Kryńska B; Zawisza E; Rewerski W
    Otolaryngol Pol; 1994; 48(5):435-40. PubMed ID: 7808749
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of nonspecific immunity to reduce the risk of recurrent infections in children attending day-care centers. The Epicrèche Research Group.
    Collet JP; Ducruet T; Kramer MS; Haggerty J; Floret D; Chomel JJ; Durr F
    Pediatr Infect Dis J; 1993 Aug; 12(8):648-52. PubMed ID: 8414777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prospective placebo-controlled double-blind study using a bacterial lysate in infections of the respiratory tract and ENT region in children].
    Schaad UB; Farine JC; Fux T
    Helv Paediatr Acta; 1986 May; 41(1-2):7-17. PubMed ID: 3755127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Value of Imocur in the prevention of recurrent infections in children under six years of age. Results of a multicenter, placebo-controlled trial].
    Paupe J
    Ann Pediatr (Paris); 1990 Sep; 37(7):475-9. PubMed ID: 2256645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of recurrent respiratory diseases using bacterial vaccines].
    Kapellerová A; Krovinová A; Jakubovská M; Kuková Z
    Cesk Pediatr; 1988 Dec; 43(12):738-40. PubMed ID: 3250745
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunostimulation in recurrent respiratory tract infections therapy in children.
    Prusek W; Jankowski A; Radomska G; Wieczorek E; Podwysocka M
    Arch Immunol Ther Exp (Warsz); 1987; 35(3):289-302. PubMed ID: 3502238
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of the number and severity of respiratory tract infections in children by oral immunostimulation.
    Riedl-Seifert RJ; van Aubel A; Kämmereit A; Elsasser U
    Adv Exp Med Biol; 1995; 371B():799-802. PubMed ID: 7502900
    [No Abstract]   [Full Text] [Related]  

  • 17. ADAPTIVE MECHANISMS OF THE IMMUNE SYSTEM IN CHILDREN IN FAR NORTH.
    Ivanova ON; Argunova EF; Alekseev SN; Ystugina TV; Varfolomeev AR; Troev IP; Kononova IV; Egorova VE
    Wiad Lek; 2015; 68(4):534-6. PubMed ID: 26887130
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The assessment of the therapeutic effectiveness of IRS-19 in allergic children with recurrent or chronic respiratory infections.
    Maciorkowska E; Kaczmarski M; Cudowska B; Stasiak-Barmuta A; Nowowiejska B
    Rocz Akad Med Bialymst; 1995; 40(3):619-24. PubMed ID: 8775316
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of thymalin in the diseases of early infancy].
    Trofimenko IA; Zotova VV; Khavinson VKh; Morozov VG; Bezverkhaia LK
    Pediatriia; 1985 Aug; (8):31-5. PubMed ID: 3840883
    [No Abstract]   [Full Text] [Related]  

  • 20. OM-85 BV: primary versus secondary prevention.
    Collet JP; Boissel JP
    Respiration; 1994; 61 Suppl 1():20-3. PubMed ID: 7800967
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.